South Korea Neurovascular Devices Market Size, Share, and COVID-19 Impact Analysis, By Types (Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, and Support Devices), By Applications (Stroke, Cerebral Artery Stenosis, Cerebral Aneurysm, and Others), and South Korea Neurovascular Devices Market Insights, Industry Trend, Forecasts to 2035

Industry: Healthcare

RELEASE DATE Aug 2025
REPORT ID SI15327
PAGES 140
REPORT FORMAT PathSoft

South Korea Neurovascular Devices Market Insights Forecasts to 2035

  • The South Korea Neurovascular Devices Market size is Expected to Grow at a CAGR of around 5.9% from 2025 to 2035
  • The South Korea Neurovascular Devices Market size is Expected to Hold a Significant Share by 2035

South Korea Neurovascular Devices Market

Get more details on this report -

Request Free Sample PDF

According to a Research Report Published by Spherical Insights & Consulting, the South Korea Neurovascular Devices Market Size is Anticipated to Grow at a CAGR of 5.9% from 2025 to 2035. The market is driven by rising stroke incidence, expanding stroke center networks, regulatory approvals, and rapid adoption of advanced endovascular technologies.

 

Market Overview

The South Korea neurovascular devices refers to the section of the market medical device industry that focuses on devices and technologies used in diagnosis and treatment of cerebrovascular disorders, including ischemic strokes, cerebral aneurysm, and distortions of arteries. This market covers embolization devices, flow divertors, thrombctomy systems, stents, microcather and access products that facilitate minimal incentive neuro-internal processes. In South Korea, the growing spread of market stroke, rapid adoption of endovskular therapy and strong growth due to government-supported expansion of stroke centers. Regulatory approval of advanced equipment such as flow divertors and liquid embellics are also increasing access and treatment options. In addition, the ongoing technological progress and cooperation between global manufacturers and local distributors continue to strengthen the market and strengthen the patient results.

 

Report Coverage

This research report categorizes the market for the South Korea neurovascular devices market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea neurovascular devices market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea neurovascular devices market.

 

South Korea Neurovascular Devices Market Report Coverage

Report CoverageDetails
Base Year:2024
Forecast Period:2024-2035
Forecast Period CAGR 2024-2035 :5.9%
Historical Data for:2020-2023
No. of Pages:140
Tables, Charts & Figures:140
Segments covered:By Types, By Applications.
Companies covered:: Medtronic, Stryker, Johnson & Johnson, MicroPort Scientific Corporation, Terumo Corporation, phenox GmbH and Others.
Pitfalls & Challenges:COVID-19 Empact, Challenge, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The South Korean neurovascular devices market is primarily driven by the increasing proliferation of stroke and aneurysm affairs, which has increased the demand for advanced endovascular treatment options. To improve access to special care, the stroke center is expanding the network and the government's initiative and accelerating more adoption. Additionally, embolization devices, thrombctomy systems, and continuous technological progression in flow divertors are improving the results of treatment. Regulatory approval and reimbursement support are also enabled rapid clinical integration, promoting the availability and use of neurovascular equipment.

 

Restraining Factors

Neurovascular device market have to face restraints such as high equipment costs, limited reimbursement policies in developing areas and stringent regulatory approval procedures. Additionally, efficient neuro-internet prohibits process versions for adoption in health systems emerging from lack of experts.

 

Market Segmentation

The South Korea neurovascular devices market share is classified into types, and applications.

 

  • The cerebral embolization and aneurysm coiling device segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea neurovascular devices market is segmented by types into cerebral embolization and aneurysm coiling devices, cerebral angioplasty and stenting systems, neurothrombectomy devices, and support devices. Among these, the cerebral embolization and aneurysm coiling devices segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is mainly due to the extensive adoption of the embolism coil jointly with increasing use of advanced flow divertors and liquid embellic agents in the treatment of cerebral aneurysm.

 

  • The stroke segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea neurovascular devices market is segmented by applications into stroke, cerebral artery stenosis, cerebral aneurysm, and others. Among these, the stroke segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This dominance is due to increasing preference for the increasing global burden of ischemic stroke, minimal inventory thrombctomy processes and expanding the availability of broader stroke care centers in developed and emerging markets.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea neurovascular devices market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Medtronic
  • Stryker
  • Johnson & Johnson
  • MicroPort Scientific Corporation
  • Terumo Corporation
  • phenox GmbH
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea neurovascular devices market based on the below-mentioned segments:

 

South Korea Neurovascular Devices Market, By Types

  • Cerebral Embolization and Aneurysm Coiling Devices
  • Cerebral Angioplasty and Stenting Systems
  • Neurothrombectomy Devices
  • Support Devices

 

South Korea Neurovascular Devices Market, By Applications

  • Stroke
  • Cerebral Artery Stenosis
  • Cerebral Aneurysm
  • Others

Frequently Asked Questions (FAQ)

  • 1. What is the forecasted CAGR of the South Korea neurovascular devices market from 2024 to 2035?
    The market is expected to grow at a CAGR of around 5.9% during the period 2024–2035.
  • 2. Can you provide company profiles for the neurovascular device manufacturers?
    Yes. For instance, Medtronic, Stryker, Johnson & Johnson, MicroPort Scientific Corporation, Terumo Corporation, and phenox GmbH.
  • 3. What are the main drivers of growth in the South Korea neurovascular devices market?
    Rising stroke incidence, expanding stroke center networks, regulatory approvals, and rapid adoption of advanced endovascular technologies.
  • 4. What challenges are limiting the adoption of the neurovascular devices market?
    High equipment costs, limited reimbursement policies in developing areas and stringent regulatory approval procedures. Additionally, efficient neuro-internet prohibits process versions for adoption in health systems emerging from lack of experts.
  • 5. Which segment dominated the market?
    The stroke segment dominated the market.

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies